In this month's newsletter, watch Dr. Ehtisham Mahmud discuss results of the PRECISION Registry at SCAI 2017
Not rendering correctly? View this email as a web page here.
PRECISION Registry Shows High Success Rates of Radial and Femoral Robotic-assisted PCI, Findings Presented at SCAI 2017
The final results of a sub-analysis of the multicenter PRECISION registry were presented during the late breaking clinical trials at SCAI 2017 in New Orleans, LA earlier this month. Data from the PRECISION study determined that high rates of clinical and technical success can be achieved in both femoral and radial access robotic-assisted PCI procedures. Ehtisham Mahmud, MD, UC San Diego School of Medicine, discussed the implications of the study’s findings, noting that the study concluded an overall clinical success rate or 97% and technical success rate of 86%.
100th Robotic-assisted PCI Procedure Performed Using 2nd Generation CorPath® GRX System
We are excited to announce the milestone of the 100th Robotic-assisted PCI procedure performed using our second generation CorPath GRX System. Since the successful launch earlier in 2017, CorPath GRX has been used in a variety of procedural settings and physicians have reported an increase in the number of procedures that can be performed robotically. "The CorPath GRX System is an important advancement in the field of interventional cardiology and I am pleased to be a part of the initial launch of this enhanced technology”, said Sunil Rao, MD, Section Chief of Cardiology at the Durham VA Medical Center.
RADMatrix Study Shows Higher Radiation Exposure for Patients and Physicians with Transradial vs. Transfemoral Access PCI via Manual Approach
Data of the RADMatrix sub-study was presented during this year’s ACC meeting, concluding that transradial access during PCI procedures is associated with higher radiation exposure in both operators and patients when compared to transfemoral access. The study found that the approximate 10% increase in radiation exposure to patients was relatively small but statistically significant; while radiation exposure to the operator’s chest resulted in a substantial increase, almost doubling the radiation dosage when performing transradial procedures compared to transfemoral procedures.
Corindus Announced Strategic Partnership with BLOXR Solutions to Distribute Line of Radiation Protection Products
We recently announced our strategic partnership with BLOXR Solutions, a leading provider of radiation protection products designed to reduce exposure for clinicians and patients, to distribute radiation protection products globally. BLOXR offers a line of lightweight protective apparel, serving as a complement to vascular robotics, to provide enhanced radiation protection for cath lab staff working at the bedside. “Protecting the physicians and staff who care for patients every day is an important part of our mission,” said Mark Toland, President and Chief Executive Officer of Corindus.
The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous coronary intervention (PCI) procedures.
The CorPath 200 System is intended for use in the remote delivery and manipulation of coronary guidewires and balloon/stent catheters during PCI procedures
The CorPath 200 System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventional procedures.
Caution: Federal law restricts this device to sale by or on the order of a physician.
Copyright Corindus, Inc. 309 Waverley Oaks Road, Suite 105, Waltham, MA 02452, US Corporate Office: 508-653-3335 | Sales & Customer Service: 800-605-9635 | Fax: 508-232-6000